TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-14 Cr | ₹-20 Cr | ₹-9.69 Cr | ₹-0.45 Cr |
What is the latest Cash Flow from Investing Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-20 Cr |
| Mar2023 | ₹-9.69 Cr |
| Mar2022 | ₹-0.45 Cr |
How is Cash Flow from Investing Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-20 Cr | Negative | |
| Mar2023 | ₹-9.69 Cr | Negative | |
| Mar2022 | ₹-0.45 Cr | - | |
Compare Cash Flow from Investing Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹300.1 Cr | 2.5% | 6% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,484.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,018.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹106,357.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 2.5% |
6% |
0.6% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses